GSK "AMITIST", Moscow

Economic indicators

Net loss (RA) of GSK AMITIST made up 371.00 thousand RUB over 2023 compared to net profit of 650.00 thousand RUB over 2022, the company informed.

Revenue decreased in the accounting period by 2.77% to 4.78 million RUB from 4.92 million RUB in 2022.

Net profit (RAS) of GSK AMITIST grew over 2022 3.01 times to 650.00 thousand RUB from 216.00 thousand RUB over 2021, the company informed.

Revenue increased in the accounting period by 11.45% to 4.92 million RUB from 4.41 million RUB over 2021.

Net profit (RAS) of GSK AMITIST made up 216.00 thousand RUB over 2021 compared to net loss of 179.00 thousand RUB over 2020, the company informed.

Revenue decreased in the accounting period by 2.93% to 4.41 million RUB from 4.54 million RUB in 2020.

Net loss (RAS) of GSK AMITIST increased 22.38 times to 179.00 thousand RUB from 8.00 thousand RUB over 2019, the company informed.

Revenue increased in the accounting period by 3.39% to 4.54 million RUB from 4.39 million RUB over 2019.

Net loss (RA) of GSK AMITIST made up 8.00 thousand RUB over 2019 compared to net profit of 199.00 thousand RUB over 2018, the company informed.

Revenue decreased in the accounting period by 3.22% to 4.39 million RUB from 4.54 million RUB in 2018.

Net profit (RAS) of GSK AMITIST dropped in 2018 by 9.55% to 199.00 thousand RUB from 220.00 thousand RUB over the same period in 2017, the company informed.

Revenue remained in the accounting period at the same level and made up 4.54 million RUB compared to 4.56 million RUB 4.56 million RUB; cost of goods sold remained at the same level amounting to 4.30 million RUB compared to 4.31 million RUB; sales profit fell by 4.31% to 244.00 thousand RUB from 255.00 thousand RUB.

Net profit (RAS) of GSK AMITIST made up 220.00 thousand RUB over 2017 compared to net loss of 8.00 thousand RUB over 2016, the company informed.

Revenue increased in the accounting period by 4.97% to 4.56 million RUB from 4.34 million RUB over 2016; cost of goods sold remained at the same level amounting to 4.31 million RUB compared to 4.29 million RUB; sales profit went up 4.72 times to 255.00 thousand RUB from 54.00 thousand RUB.

Net loss (RA) of GSK AMITIST made up 8.00 thousand RUB over 2016 compared to net profit of 48.00 thousand RUB over 2015, the company informed.

Revenue decreased in the accounting period by 11.64% to 4.34 million RUB from 4.92 million RUB in 2015; cost of goods sold decreased by 9.42% to 4.29 million RUB from 4.74 million RUB; sales profit fell 3.33 times to 54.00 thousand RUB from 180.00 thousand RUB.

Companies in the region

• KRASNYY TREUGOL'NIK
• FITOFLOR
• AKI 3
• "GALLIYA-OPTIM "(OTDEL 15)
• VMTEKHPROMUZEL